Home / Events / Cracking the Code on Generative AI: From Hype to Impact


Cracking the Code on Generative AI: From Hype to Impact

Available On Demand

Watched our AIML 101 webinar and ready to learn more? Trinity Life Sciences is excited to continue the conversation with our next webinar, which will dive deeper into how pharma companies can move beyond the hype to unlock the value of Generative AI (GenAI).

Join Trinity experts, Steve Laux, VP of Commercial Insights & Advanced Analytics, Nabha Subramanya, VP of Data Science and Patrick Waring, Director of New Products & Strategy, as they sift through all the noise surrounding GenAI and share real-life use cases and practical actions that you should be doing now to drive impact for your organization.

AIML is here. Be ready with Trinity.

Key Webinar Topics

  • Examine the current landscape of GenAI in the pharma industry 
  • Explore real-life, practical use cases of GenAI in pharma, with a focus on what’s working and what’s not
  • Address the challenges of implementing GenAI, such as the rapidly changing tech stack 
  • Prioritize use cases based on their potential value for your organization 
  • Learn about Trinity’s framework for evaluating and implementing GenAI


Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.